Srs Capital Advisors, Inc. 10x Genomics, Inc. Transaction History
Srs Capital Advisors, Inc.
- $1.5 Billion
- Q4 2024
A detailed history of Srs Capital Advisors, Inc. transactions in 10x Genomics, Inc. stock. As of the latest transaction made, Srs Capital Advisors, Inc. holds 4,853 shares of TXG stock, worth $48,287. This represents 0.0% of its overall portfolio holdings.
Number of Shares
4,853
Previous 529
817.39%
Holding current value
$48,287
Previous $11,000
527.27%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding TXG
# of Institutions
302Shares Held
96.5MCall Options Held
76.4KPut Options Held
132K-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl11.9MShares$119 Million1.5% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.9MShares$109 Million0.0% of portfolio
-
Black Rock Inc. New York, NY6.39MShares$63.6 Million0.0% of portfolio
-
Sumitomo Mitsui Trust Holdings, Inc.5.71MShares$56.8 Million0.06% of portfolio
-
Nikko Asset Management Americas, Inc.5.71MShares$56.8 Million0.92% of portfolio
About 10x Genomics, Inc.
- Ticker TXG
- Exchange NASDAQ
- Sector Healthcare
- Industry Health Information Services
- Shares Outstandng 95,046,400
- Market Cap $946M
- Description
- 10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumabl...